Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-09 Sale | 2025-12-09 10:26 am | Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director | 9,398 | $0 | $0 | 0 (Direct) | View |
| 2025-12-09 Sale | 2025-12-09 10:25 am | Akero Therapeutics Inc. | AKRO | Xu Yuan Director | 9,398 | $0 | $0 | 0 (Direct) | View |
| 2025-12-09 Sale | 2025-12-09 10:24 am | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 436,837 | $0 | $0 | 0 (Direct) | View |
| 2025-12-09 Sale | 2025-12-09 10:21 am | Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director | 293,762 | $0 | $0 | 0 (Indirect Direct) | View |
| 2025-12-09 Sale | 2025-12-09 10:17 am | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 1,302,398 | $0 | $0 | 0 (Indirect Direct) | View |
| 2025-12-09 Sale | 2025-12-09 10:17 am | Akero Therapeutics Inc. | AKRO | Judy Chou Director | 9,398 | $0 | $0 | 0 (Direct) | View |
| 2025-12-09 Sale | 2025-12-09 10:14 am | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 282,149 | $0 | $0 | 0 (Direct) | View |
| 2025-12-09 Sale | 2025-12-09 10:14 am | Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director | 9,398 | $0 | $0 | 0 (Direct) | View |
| 2025-12-09 Sale | 2025-12-09 10:11 am | Akero Therapeutics Inc. | AKRO | Gangloff Scott A. Chief Technology Officer | 26,351 | $0 | $0 | 0 (Direct) | View |
| 2025-12-09 Sale | 2025-12-09 10:11 am | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 57,752 | $0 | $0 | 0 (Direct) | View |
| 2025-12-09 Sale | 2025-12-09 10:06 am | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 74,800 | $0 | $0 | 0 (Direct) | View |
| 2025-12-09 Sale | 2025-12-09 10:06 am | Akero Therapeutics Inc. | AKRO | Lamy Patrick See Remarks | 29,891 | $0 | $0 | 0 (Direct) | View |
| 2025-12-09 Sale | 2025-12-09 10:06 am | Akero Therapeutics Inc. | AKRO | Henderson Jane Director | 9,398 | $0 | $0 | 0 (Direct) | View |
| 2025-12-09 Sale | 2025-12-09 10:03 am | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 260,189 | $0 | $0 | 0 (Indirect Direct) | View |
| 2025-10-10 Sale | 2025-10-14 8:11 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 30,000 | $53.98 | $1,619,340 | 906,131 (Direct) | View |
| 2025-10-07 Sale | 2025-10-09 6:58 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $46.08 | $576,001 | 216,516 (Direct) | View |
| 2025-10-01 Sale | 2025-10-03 4:30 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $47.76 | $596,978 | 301,880 (Indirect Direct) | View |
| 2025-09-11 Sale | 2025-09-12 8:39 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 586 | $43.02 | $25,210 | 256,898 (Indirect Direct) | View |
| 2025-09-11 Sale | 2025-09-12 8:39 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 659 | $43.02 | $28,350 | 90,829 (Direct) | View |
| 2025-09-11 Sale | 2025-09-12 8:38 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 659 | $43.02 | $28,350 | 57,752 (Direct) | View |
| 2025-09-11 Sale | 2025-09-12 8:36 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 553 | $43.02 | $23,790 | 166,571 (Direct) | View |
| 2025-09-10 Sale | 2025-09-12 8:36 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 31,796 | $43.23 | $1,374,665 | 883,919 (Direct) | View |
| 2025-09-08 Sale | 2025-09-10 7:48 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $44.17 | $552,137 | 229,958 (Direct) | View |
| 2025-09-02 Sale | 2025-09-04 7:47 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $46.08 | $576,035 | 314,966 (Indirect Direct) | View |
| 2025-08-12 Sale | 2025-08-13 6:37 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $47.79 | $597,326 | 327,466 (Indirect Direct) | View |
| 2025-08-11 Sale | 2025-08-13 6:37 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 30,000 | $48.59 | $1,457,596 | 490,757 (Direct) | View |
| 2025-08-12 Sale | 2025-08-12 8:32 pm | Akero Therapeutics Inc. | AKRO | Henderson Jane Director | 3,000 | $47.46 | $142,371 | 21,195 (Direct) | View |
| 2025-08-05 Sale | 2025-08-07 09:00 am | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $49.3 | $616,299 | 174,557 (Direct) | View |
| 2025-07-16 Sale | 2025-07-18 6:00 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 10,000 | $52.95 | $529,467 | 222,693 (Direct) | View |
| 2025-07-10 Sale | 2025-07-11 6:30 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 30,000 | $51.16 | $1,534,895 | 520,757 (Direct) | View |
| 2025-07-07 Sale | 2025-07-09 7:00 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $51.09 | $638,661 | 187,057 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-11-25 Exercise | 2025-11-28 06:03 am | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 97,064 | $0.615 | 282,149 (Direct) | View |
| 2025-11-25 Exercise | 2025-11-28 06:03 am | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 3,527 | $28.35 | 282,149 (Direct) | View |
| 2025-11-25 Exercise | 2025-11-28 06:03 am | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 4,284 | $21.09 | 282,149 (Direct) | View |
| 2025-11-25 Exercise | 2025-11-28 06:03 am | N/A 2028-07-29 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 152,678 | $0 | 282,149 (Direct) | View |
| 2025-11-25 Exercise | 2025-11-28 06:03 am | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 43,064 | $6.364 | 282,149 (Direct) | View |
| 2025-11-25 Exercise | 2025-11-28 06:03 am | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 4,739 | $21.1 | 282,149 (Direct) | View |
| 2025-11-24 Exercise | 2025-11-26 4:03 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 4,284 | $21.09 | 260,189 (Direct) | View |
| 2025-11-24 Exercise | 2025-11-26 4:03 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 3,527 | $28.35 | 260,189 (Direct) | View |
| 2025-11-24 Exercise | 2025-11-26 4:03 pm | N/A 2029-12-12 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,550 | $0 | 260,189 (Direct) | View |
| 2025-11-26 Gift | 2025-11-26 4:03 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 9,259 | $0 | 260,189 (Direct) | View |
| 2025-11-24 Exercise | 2025-11-26 4:03 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 4,739 | $21.1 | 260,189 (Direct) | View |
| 2025-11-20 Gift | 2025-11-21 6:25 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 74,538 | $0 | 436,837 (Direct) | View |
| 2025-11-17 Gift | 2025-11-19 8:04 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 37,100 | $0 | 129,471 (Direct) | View |
| 2025-11-12 Gift | 2025-11-13 8:03 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 14,739 | $0 | 511,375 (Direct) | View |
| 2025-11-04 Exercise | 2025-11-06 07:00 am | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 3,527 | $28.35 | 74,800 (Direct) | View |
| 2025-11-04 Exercise | 2025-11-06 07:00 am | N/A 2030-12-07 | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 8,266 | $0 | 74,800 (Direct) | View |
| 2025-11-04 Exercise | 2025-11-06 07:00 am | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 4,739 | $21.1 | 74,800 (Direct) | View |
| 2025-10-10 Exercise | 2025-10-14 8:11 pm | N/A 2033-12-07 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 30,000 | $0 | 906,131 (Direct) | View |
| 2025-10-10 Exercise | 2025-10-14 8:11 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 30,000 | $19.87 | 906,131 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-10 7:48 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 13,000 | $25.2 | 1,293,000 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-10 7:48 pm | N/A 2034-06-07 | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 90,832 | $0 | 1,293,000 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-10 7:48 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 15,000 | $8.13 | 1,293,000 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-10 7:48 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 26,000 | $23.02 | 1,293,000 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-10 7:48 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 23,832 | $19.97 | 1,293,000 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-10 7:48 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 13,000 | $26.32 | 1,293,000 (Direct) | View |
| 2025-10-07 Exercise | 2025-10-09 6:58 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $28.35 | 216,516 (Direct) | View |
| 2025-10-07 Exercise | 2025-10-09 6:58 pm | N/A 2030-12-07 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $0 | 216,516 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-09 6:58 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 52,212 | $0.615 | 526,114 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-09 6:58 pm | N/A 2028-09-07 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 52,212 | $0 | 526,114 (Direct) | View |
| 2025-10-01 Exercise | 2025-10-03 4:30 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $0 | 301,880 (Direct) | View |
| 2025-10-01 Exercise | 2025-10-03 4:30 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $21.1 | 301,880 (Direct) | View |
| 2025-09-10 Exercise | 2025-09-12 8:36 pm | N/A 2029-01-15 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 14,941 | $0 | 883,919 (Direct) | View |
| 2025-09-10 Exercise | 2025-09-12 8:36 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 1,919 | $19.87 | 883,919 (Direct) | View |
| 2025-09-10 Exercise | 2025-09-12 8:36 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 13,022 | $6.364 | 883,919 (Direct) | View |
| 2025-09-08 Exercise | 2025-09-10 7:48 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 7,044 | $21.09 | 229,958 (Direct) | View |
| 2025-09-08 Exercise | 2025-09-10 7:48 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 295 | $28.35 | 229,958 (Direct) | View |
| 2025-09-08 Exercise | 2025-09-10 7:48 pm | N/A 2029-12-12 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $0 | 229,958 (Direct) | View |
| 2025-09-08 Exercise | 2025-09-10 7:48 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 5,161 | $6.364 | 229,958 (Direct) | View |
| 2025-09-02 Exercise | 2025-09-04 7:47 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $0 | 314,966 (Direct) | View |
| 2025-09-02 Exercise | 2025-09-04 7:47 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $21.1 | 314,966 (Direct) | View |
| 2025-08-15 Exercise | 2025-08-19 9:32 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Gangloff Scott A. Chief Technology Officer | 2,600 | $19.62 | 44,135 (Direct) | View |
| 2025-08-15 Exercise | 2025-08-19 9:32 pm | N/A 2034-04-28 | Akero Therapeutics Inc. | AKRO | Gangloff Scott A. Chief Technology Officer | 2,600 | $0 | 44,135 (Direct) | View |
| 2025-08-12 Exercise | 2025-08-13 6:37 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $0 | 327,466 (Direct) | View |
| 2025-08-12 Exercise | 2025-08-13 6:37 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $21.1 | 327,466 (Direct) | View |
| 2025-08-12 Exercise | 2025-08-12 8:32 pm | N/A 2029-04-02 | Akero Therapeutics Inc. | AKRO | Henderson Jane Director | 3,000 | $0 | 21,195 (Direct) | View |
| 2025-08-12 Exercise | 2025-08-12 8:32 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Henderson Jane Director | 3,000 | $7.009 | 21,195 (Direct) | View |
| 2025-08-05 Exercise | 2025-08-07 09:00 am | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $21.09 | 174,557 (Direct) | View |
| 2025-08-05 Exercise | 2025-08-07 09:00 am | N/A 2029-12-12 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $0 | 174,557 (Direct) | View |
| 2025-07-16 Exercise | 2025-07-18 6:00 pm | N/A 2033-12-07 | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 10,000 | $0 | 222,693 (Direct) | View |
| 2025-07-16 Exercise | 2025-07-18 6:00 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 10,000 | $19.87 | 222,693 (Direct) | View |
| 2025-07-07 Exercise | 2025-07-09 7:00 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $21.09 | 187,057 (Direct) | View |
| 2025-07-07 Exercise | 2025-07-09 7:00 pm | N/A 2029-12-12 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 12,500 | $0 | 187,057 (Direct) | View |